EarningsBull
Novanta Q2 Beats Estimates, Raises FY Guidance
Revenue and EPS beat estimates, FY guidance raised, confirming prior optimism
D1 -2.7% · +5d +11.1%
›2 waves of this story
- 2026-07-29 Two Zacks articles highlight key ingredients for a likely beat and an impressive earnings surprise history
- 2026-08-06 Revenue and EPS beat estimates, FY guidance raised, confirming prior optimism
Earnings
Earnings report
D1 -4.0% · +5d +9.1%
4 earlier events›
Earnings
Earnings report
D1 +7.5% · +5d +5.2%
CapitalBear
American Capital Management Cuts Novanta Stake by 2.1%
Institution reduced position in Q1, stake valued at $44.16 million
D1 +0.6% · +5d +12.6%
CompanyBull
Novanta Completes Acquisition of Riverpoint Medical
Company announces completion of acquisition, expanding medical technology footprint
D1 -0.5% · +5d +5.4%
Earnings
Earnings report
D1 +1.2% · +5d +8.1%
be the first
Be civil · your views are your own
Facts and opinions separated · All items sourced · Not investment advice